Jason Dinges has been a member of the investment team at Morningside Technology Advisory since 2011, and has extensive experience providing operational and management oversight to early-stage biotechnology companies. Morningside was founded by the Chan family of Hong Kong to make private equity and venture capital investments; he serves on the boards of Morningside’s portfolio companies including Matatu. He spent five years as an IP attorney with Foley & Lardner. He received a PhD in genetics from Iowa State University, and his JD from the University of Iowa College of Law.